Theravance Biopharma News and Activities
Presence
Theravance Biopharma develops and commercializes prescription medicines. Its products and pipeline focus on respiratory, neurological, and hospital care treatments for patients, healthcare providers, and pharmaceutical partners.
Theravance Biopharma products and services overview:
- Respiratory medicines
- Neurology treatments
- Hospital therapies
- Prescription drugs
- Drug development
- Royalty assets
Revenue: ~$60 million
Employees: 120
Headquarters: South San Francisco, United States (USA)
Theravance Biopharma is one of the...
Theravance Biopharma is a company listed under the stock ticker TBPH (US).
Executives
View the org chart displaying its 22 main executives
Most searched biographies at Theravance Biopharma
- Rick Winningham, Chairman of the Board and Chief Executive Officer
- Eran Broshy, Director
- Dean Mitchell, Director
Create your alert
to follow the executive moves at Theravance Biopharma.
Pharmaceuticals
Theravance Biopharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Theravance Biopharma
- Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update | Theravance Biopharma
- Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023 | Theravance Biopharma
- Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders | Theravance Biopharma
- Theravance Biopharma to Participate in an Upcoming Investor Conference | Theravance Biopharma
- Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update | Theravance Biopharma
- Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023 | Theravance Biopharma
- Theravance Biopharma to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023 | Theravance Biopharma
- News Releases | Theravance Biopharma
- News Releases | Theravance Biopharma
- Theravance Biopharma to Report Third Quarter 2020 Financial Results on November 5, 2020 :: Theravance Biopharma
- View more press releases Close
Social media about Theravance Biopharma
- Theravance Biopharma on Wikipedia, Google News & Yahoo Finance
- Theravance Biopharma on LinkedIn, X (Twitter) & YouTube
